According to the Report, the Size of the Coagulation/Hemostasis analyzer market is expected to reach USD 4.84 billion by 2024, growing at a CAGR of 10.2% during the forecast period 2019 - 2024.
These analyzers are very much helpful in examining the hemostasis system in laboratories. Coagulometers are used in various methods such as to observe blood clots in the blood. Coagulation analyzers follow easy steps to measure blood platelet levels. The early diagnosis of the hemostasis system can prevent blood clots which might cause heart attacks. Most importantly coagulation analyzers can evaluate the thromboline and thromboplastine concentrations in very less time. Also, these analyzers are user-friendly as they can evaluate the required measurement in a few minutes and which helps to prevent bleeding to blood clots.
The major factor driving the demand of the market is the rising number of cardiovascular problems across the world. Changes in lifestyles and increasing obesity cases due to changes in food habits are also some common factors propelling the growth rate of the coagulation/hemostasis market. In addition, creating awareness over the availability of diagnostics procedures that can prevent heart attacks is enhancing the demand of this market. A growing number of people suffering from blood disorders is accelerating the growth rate of the market to the extent.
However, lack of standardization is slowly hindering the growth rate of the market. Automatic coagulation analyzers require huge amounts for installation and maintenance which is remained as a challenging factor for the market developers. Strict rules and regulations by government organizations in approving medical equipment are also impeding the growth rate of the coagulation/hemostasis analyzers market. The availability of alternative devices that are highly advanced at a lower price is quietly limiting the demand of the market. People in rural areas are less aware of these techniques due to lack of proper knowledge in the utilization of the analyzers and this is degrading the growth rate of the market.
Focus on the development of innovative techniques and the rise in the number of research centers in the biotechnology field is to create growth opportunities for the coagulation/hemostasis analyzers market. Increasing prevalence for automation equipment in laboratories is greatly influencing the demand of the market eventually. The growing geriatric population is also one of the factors gearing up the growth rate of the market. Constant economic growth in both developed and developing countries is lucratively surging the demand of the market. Increasing investments in healthcare by private and public organizations is also impacting the demand of the market towards positive.
Recent Developments:
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 - 2024 |
|
Segments Covered |
By Tests, Products, End Users, Technology, Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
Siemens AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Roche Diagnostics (Switzerland), Alere Inc. (U.S.), Sysmex Corporation (Japan), Helena Laboratories (U.S.), Instrumentation Laboratory (U.S.), International Technidyne Corporation (U.S.), Nihon Kohden Corporation (Japan) and Diagnostica Stago (France). |
This research report on the Global Coagulation/Hemostasis Analyzer Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.
Coagulation/Hemostasis Analyzer Market - By Test
On the basis of test, prothrombin time testing has the largest market share in this segment and is also the fastest-growing due to increasing automation of this process in laboratories.
Coagulation/Hemostasis Analyzer Market - By Product
On the basis of product, Clinical laboratory analyzers have the largest market in this segment.
Coagulation/Hemostasis Analyzer Market - By End Users
On the basis of end-user, Clinical laboratories have the largest share in the segment.
Coagulation/Hemostasis Analyzer Market - By Technology
On the basis of technology, the Optical segment has the largest market share and is also the fastest-growing in this segment.
Regional Analysis
North America holds the largest market share in the world due to the rising geriatric population and the rising incidence of chronic blood disorders. Europe is expected to have the second-largest share. Asia-Pacific is expected to have the fastest growth as a result of a huge number of patients, booming economy and poor lifestyle choices.
Key Market Participants dominating the Global Coagulation/Hemostasis Analyzer Market Profiled in the Report are
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Test
5.1.1 ACT
5.1.2 aPTT
5.1.3 D Dimer testing
5.1.4 Platelet Function Test
5.1.5 Prothrombin Time Testing
5.1.6 Anti-Factor Xa Test
5.1.7 Heparin and Protamine Dose Response Test for ACT
5.1.8 Fibrinogen Testing
5.1.9 Other Coagulation Tests
5.1.10 Y-o-Y Growth Analysis, By Test
5.1.11 Market Attractiveness Analysis, By Test
5.1.12 Market Share Analysis, By Test
5.2 Product
5.2.1 PoC Testing Analyzers
5.2.2 Clinical Laboratory Analyzers
5.3 End Users
5.3.1 Clinical Laboratories
5.3.2 Point-Of-Care Testing
5.3.3 Other End Users
5.3.4 Y-o-Y Growth Analysis, By End Users
5.3.5 Market Attractiveness Analysis, By End Users
5.3.6 Market Share Analysis, By End Users
5.4 Technology
5.4.1 Electrochemical Technology
5.4.2 Optical Technology
5.4.3 Mechanical Technology
5.4.4 Other Technologies
5.4.5 Y-o-Y Growth Analysis, By Technology
5.4.6 Market Attractiveness Analysis, By Technology
5.4.7 Market Share Analysis, By Technology
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Test
6.1.3.2 By Product
6.1.3.3 By End Users
6.1.3.4 By Technology
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Test
6.1.4.2 By Product
6.1.4.3 By End Users
6.1.4.4 By Technology
6.1.5 Market Share Analysis
6.1.5.1 By Test
6.1.5.2 By Product
6.1.5.3 By End Users
6.1.5.4 By Technology
6.2 North America
6.2.1 Introduction
6.2.2 United States
6.2.3 Canada
6.3 Europe
6.3.1 Introduction
6.3.2 U.K
6.3.3 Spain
6.3.4 Germany
6.3.5 Italy
6.3.6 France
6.4 Asia-Pacific
6.4.1 Introduction
6.4.2 China
6.4.3 India
6.4.4 Japan
6.4.5 Australia
6.4.6 South Korea
6.5 Latin America
6.5.1 Introduction
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Rest of Latin America
6.6 Middle East & Africa
6.6.1 Introduction
6.6.2 Middle-East
6.6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Siemens AG
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific Inc.
8.3 Roche Diagnostics
8.4 Alere Inc.
8.5 Sysmex Corporation
8.6 Helena Laboratories
8.7 Instrumentation Laboratory
8.8 International Technidyne Corporation
8.9 Nihon Kohden Corporation
8.10 Diagnostica Stago
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Aug 2019
Download Sample
Aug 2019
Download Sample
Aug 2019
Download Sample
Aug 2019
Download Sample
